BNO - Company Update - Dr Deborah Rathjen, CEO and MD
Achieves Significant Milestones: BNC105 & 210, Genmab, Merck Serono Agreement
Thu, 17 Jul 2008 3:00pm
Loading presentation... If nothing happens, you may need to install Flash and/or enable javascript in your browser.
Email Presenter Share BRR Media
Your Email
Message
Message currently sending ... Sending ...
Your Email
Recipient's Email
Message:
Message currently sending ... Sending ...
Tweet